Otros idiomas Amniotics AB

Acciones

AMNI

SE0015961016

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 15:25:49 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0038 ^SEK	0,00 %		0,00 %	-57,78 %

22/02	Amniotics AB (publ) presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
22/02	Amniotics AB (publ) informa de los resultados del cuarto trimestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Magle Chemoswed Q1 - Expansion by acquisition	19/04
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB	05/04
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total	22/03
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed	22/03
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB	22/03
Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	22/03
Amniotics secures short-term capital needs by extending loan agreement and entering into a service agreement	21/03
Amniotics announces the outcome of the exercise of warrants series TO 3	11/03
The exercise period for warrants series TO 3 in Amniotics begins today	26/02
Amniotics Q4 2023 - Investigator-sponsored trial in lung transplantation needs funding	26/02
Amniotics AB (publ) Report for the fourth quarter 2023.	22/02
Amniotics AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Amniotics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Information about the Annual General Meeting and appointed Nomination Committee of Amniotics	21/12
Amniotics Secures Orphan Designation for Lung Injury Therapy from European Commission	14/12
Amniotics receives orphan designation for PulmoStem® from the European Commission for the Treatment of Primary Graft Dysfunction following Lung Transplantation	14/12
Amniotics Q3 2023 - Rights Issue Foundation for Lung Transplantation Study	28/11
Amniotics AB (publ) Report for the third Quarter 2023	27/11
Amniotics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/11
Amniotics AB Gets Renewed GMP Certification for Medicinal Products Manufacturing Site	23/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Amniotics AB

Acciones

AMNI

SE0015961016

Otros idiomas

Filtros